Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country.

@article{Rajappa2008ImatinibMI,
  title={Imatinib mesylate in early chronic phase chronic myeloid leukemia: Experience from a developing country.},
  author={Senthil Jagannathan Rajappa and Lalit Varadpande and Tara Roshni Paul and R. T. Jacob and Raghunadharao Digumarti},
  journal={Leukemia & lymphoma},
  year={2008},
  volume={49 3},
  pages={554-8}
}
There are few publications on responses of patients with chronic phase chronic myeloid leukemia (CP-CML) from the Indian sub continent to imatinib mesylate (IM). This study analyses the response rates, progression free survival (PFS), overall survival and adverse events of early CP-CML patients on IM. Analysis of patients with untreated early CP-CML on IM from 2003 to 2006 was done. Standard criteria for hematological and cytogenetic responses were used. There were 201 patients with a median… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…